On May 6th, from 16:00-17:15, our keynote speaker will be Prof. Dr. Antonio Moschetta of the University of Bari Aldo Moro in Italy. He will be joined by Xinwei Chang of the Maastricht UMC.
Prof. Dr. Antonio Moschetta (University of Bari Aldo Moro)
Antonio Moschetta received his M.D. from the University of Bari Aldo Moro, Italy, in 1997 and his Ph.D. from Utrecht University, the Netherlands, in 2001. From 2003 to 2005, he was a research associate at the Howard Hughes Medical Institute in the Department of Pharmacology at UTSouthwestern Medical Center, Dallas, Texas, USA. He is currently Professor in Internal Medicine at the University of Bari Aldo Moro. His research focuses on the relationship between nutrients and disorders related to the gut–liver axis, with a special emphasis on the role of nuclear receptor-
mediated transcriptional programmes in cholestasis, and hepatic and colon cancer. He has published more than 100 original research papers and has been awarded several prizes including the David Williams Award (2011) from the Aspen Lipid Conference, the Rising Star in Gastroenterology and Hepatology (2012) from the United European Gastroenterology Week (UEGW), and the Richard E. Weizman Award (2014) from the Endocrine Society.
Xinwei Chang (Maastricht UMC)
Xinwei Chang, MD, MSc, is PhD candidate in the Department of Surgery, School of Nutrition and Translational Research in Metabolism, at the Maastricht University. He joined the group of Prof. Steven Olde Damink and Dr. Frank Schaap in 2017 after he earned his Master degree in Surgery in China. Xinwei Chang is the member of the European Association for the Study of the Liver and the Dutch Association for Hepatology. He focuses on assessing the role of bile salt signalling on gastrointestinal and liver diseases. He is conducting research studies evaluating chyme reinfusion on bile salt/FGF19 signalling in intestinal failure patients, and studying the mechanism of bile salt receptor agonist in promoting portal vein embolization-induced liver growth.